Multicenter Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical - a Prospective Study on Total Indications
Status: Recruiting
Location: See all (4) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
Multicenter Post market clinical follow-up Study on the Safety and Performance of Ennovate® Cervical - Prospective, pure data collection of all Ennovate Cervical patients in Total Indications
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patient is minimum 18 years old
• Informed Consent in the documentation of clinical and radiological results
• Patient has indication according to Instructions for Use (IFU)
• Patient is not pregnant
Locations
Other Locations
Germany
Städtisches Klinikum Dresden
NOT_YET_RECRUITING
Dresden
Berufsgenossenschaft Klinikum Bergmannstrost Halle / Saale
RECRUITING
Halle
Schön Klinik Hamburg Eilbek
ACTIVE_NOT_RECRUITING
Hamburg
Krankenhaus Ludmillenstift Meppen
NOT_YET_RECRUITING
Meppen
Contact Information
Primary
Sarah Mattes
sarah.mattes@aesculap.de
+497461950
Backup
Stefan Maenz, Dr.
stefan.maenz@aesculap.de
+497461950
Time Frame
Start Date: 2021-07-21
Estimated Completion Date: 2026-12
Participants
Target number of participants: 200
Treatments
Ennovate® Cervical
Alll patients which were treated with the Ennovate® Cervical system in accordance with the indications given in the instructions for use
Related Therapeutic Areas
Sponsors
Leads: Aesculap AG
Collaborators: Raylytic GmbH